SYN ($1.30) Reminder - Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that Jeffrey Riley, CEO, is scheduled to present at the 3rd Annual Marcum LLP MicroCap Conference on Thursday, May 29, 2014 in New York City at the Grand Hyatt Hotel. Mr. Riley is scheduled to present at 4:30 p.m. (Eastern Time).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.